Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium

Seung-Woo Cho, So Jung Gwak, Il Kwon Kim, Myeong Chan Cho, Kyung Kuk Hwang, Jin Sook Kwon, Cha Yong Choi, Kyung Jong Yoo, Byung Soo Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We tested the hypothesis that granulocyte colony-stimulating factor (G-CSF) administration would enhance the efficacy of cellular cardiomyoplasty with embryonic stem (ES) cell-derived cardiomyocytes in infarcted myocardium. Three weeks after myocardial infarction by cryoinjury, Sprague-Dawley rats were randomized to receive either an injection of medium, ES cell-derived cardiomyocyte transplantation, G-CSF administration, or a combination of G-CSF administration and ES cell-derived cardiomyocyte transplantation. Eight weeks after treatment, the cardiac tissue formation, neovascularization, and apoptotic activity in the infarct regions were evaluated by histology and immunohistochemistry. The left ventricular (LV) dimensions and function of the treated heart were evaluated by echocardiography. Transplanted ES cell-derived cardiomyocytes survived and participated in the myocardial regeneration in the infarcted heart. A combination of G-CSF treatment and ES cell-derived cardiomyocyte transplantation significantly promoted angiogenesis and reduced the infarct area and cell apoptosis in the infarcted myocardium compared with ES cell-derived cardiomyocyte transplantation alone. The combination therapy also attenuated LV dilation, as compared with ES cell-derived cardiomyocyte transplantation alone. G-CSF treatment can enhance the efficacy of cellular cardiomyoplasty by ES cell-derived cardiomyocyte transplantation to treat myocardial infarction.

Original languageEnglish
Pages (from-to)573-582
Number of pages10
JournalBiochemical and Biophysical Research Communications
Volume340
Issue number2
DOIs
Publication statusPublished - 2006 Feb 10

Fingerprint

Cardiomyoplasty
Granulocyte Colony-Stimulating Factor
Embryonic Stem Cells
Stem cells
Cardiac Myocytes
Myocardium
Transplantation
Myocardial Infarction
Echocardiography
Histology
Therapeutics
Left Ventricular Function
Sprague Dawley Rats
Rats
Regeneration
Dilatation
Immunohistochemistry
Tissue
Apoptosis
Injections

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Cho, Seung-Woo ; Gwak, So Jung ; Kim, Il Kwon ; Cho, Myeong Chan ; Hwang, Kyung Kuk ; Kwon, Jin Sook ; Choi, Cha Yong ; Yoo, Kyung Jong ; Kim, Byung Soo. / Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 340, No. 2. pp. 573-582.
@article{3c812cbe403243338922bdd36cb2fb10,
title = "Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium",
abstract = "We tested the hypothesis that granulocyte colony-stimulating factor (G-CSF) administration would enhance the efficacy of cellular cardiomyoplasty with embryonic stem (ES) cell-derived cardiomyocytes in infarcted myocardium. Three weeks after myocardial infarction by cryoinjury, Sprague-Dawley rats were randomized to receive either an injection of medium, ES cell-derived cardiomyocyte transplantation, G-CSF administration, or a combination of G-CSF administration and ES cell-derived cardiomyocyte transplantation. Eight weeks after treatment, the cardiac tissue formation, neovascularization, and apoptotic activity in the infarct regions were evaluated by histology and immunohistochemistry. The left ventricular (LV) dimensions and function of the treated heart were evaluated by echocardiography. Transplanted ES cell-derived cardiomyocytes survived and participated in the myocardial regeneration in the infarcted heart. A combination of G-CSF treatment and ES cell-derived cardiomyocyte transplantation significantly promoted angiogenesis and reduced the infarct area and cell apoptosis in the infarcted myocardium compared with ES cell-derived cardiomyocyte transplantation alone. The combination therapy also attenuated LV dilation, as compared with ES cell-derived cardiomyocyte transplantation alone. G-CSF treatment can enhance the efficacy of cellular cardiomyoplasty by ES cell-derived cardiomyocyte transplantation to treat myocardial infarction.",
author = "Seung-Woo Cho and Gwak, {So Jung} and Kim, {Il Kwon} and Cho, {Myeong Chan} and Hwang, {Kyung Kuk} and Kwon, {Jin Sook} and Choi, {Cha Yong} and Yoo, {Kyung Jong} and Kim, {Byung Soo}",
year = "2006",
month = "2",
day = "10",
doi = "10.1016/j.bbrc.2005.12.044",
language = "English",
volume = "340",
pages = "573--582",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium. / Cho, Seung-Woo; Gwak, So Jung; Kim, Il Kwon; Cho, Myeong Chan; Hwang, Kyung Kuk; Kwon, Jin Sook; Choi, Cha Yong; Yoo, Kyung Jong; Kim, Byung Soo.

In: Biochemical and Biophysical Research Communications, Vol. 340, No. 2, 10.02.2006, p. 573-582.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium

AU - Cho, Seung-Woo

AU - Gwak, So Jung

AU - Kim, Il Kwon

AU - Cho, Myeong Chan

AU - Hwang, Kyung Kuk

AU - Kwon, Jin Sook

AU - Choi, Cha Yong

AU - Yoo, Kyung Jong

AU - Kim, Byung Soo

PY - 2006/2/10

Y1 - 2006/2/10

N2 - We tested the hypothesis that granulocyte colony-stimulating factor (G-CSF) administration would enhance the efficacy of cellular cardiomyoplasty with embryonic stem (ES) cell-derived cardiomyocytes in infarcted myocardium. Three weeks after myocardial infarction by cryoinjury, Sprague-Dawley rats were randomized to receive either an injection of medium, ES cell-derived cardiomyocyte transplantation, G-CSF administration, or a combination of G-CSF administration and ES cell-derived cardiomyocyte transplantation. Eight weeks after treatment, the cardiac tissue formation, neovascularization, and apoptotic activity in the infarct regions were evaluated by histology and immunohistochemistry. The left ventricular (LV) dimensions and function of the treated heart were evaluated by echocardiography. Transplanted ES cell-derived cardiomyocytes survived and participated in the myocardial regeneration in the infarcted heart. A combination of G-CSF treatment and ES cell-derived cardiomyocyte transplantation significantly promoted angiogenesis and reduced the infarct area and cell apoptosis in the infarcted myocardium compared with ES cell-derived cardiomyocyte transplantation alone. The combination therapy also attenuated LV dilation, as compared with ES cell-derived cardiomyocyte transplantation alone. G-CSF treatment can enhance the efficacy of cellular cardiomyoplasty by ES cell-derived cardiomyocyte transplantation to treat myocardial infarction.

AB - We tested the hypothesis that granulocyte colony-stimulating factor (G-CSF) administration would enhance the efficacy of cellular cardiomyoplasty with embryonic stem (ES) cell-derived cardiomyocytes in infarcted myocardium. Three weeks after myocardial infarction by cryoinjury, Sprague-Dawley rats were randomized to receive either an injection of medium, ES cell-derived cardiomyocyte transplantation, G-CSF administration, or a combination of G-CSF administration and ES cell-derived cardiomyocyte transplantation. Eight weeks after treatment, the cardiac tissue formation, neovascularization, and apoptotic activity in the infarct regions were evaluated by histology and immunohistochemistry. The left ventricular (LV) dimensions and function of the treated heart were evaluated by echocardiography. Transplanted ES cell-derived cardiomyocytes survived and participated in the myocardial regeneration in the infarcted heart. A combination of G-CSF treatment and ES cell-derived cardiomyocyte transplantation significantly promoted angiogenesis and reduced the infarct area and cell apoptosis in the infarcted myocardium compared with ES cell-derived cardiomyocyte transplantation alone. The combination therapy also attenuated LV dilation, as compared with ES cell-derived cardiomyocyte transplantation alone. G-CSF treatment can enhance the efficacy of cellular cardiomyoplasty by ES cell-derived cardiomyocyte transplantation to treat myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=29644438615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29644438615&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.12.044

DO - 10.1016/j.bbrc.2005.12.044

M3 - Article

VL - 340

SP - 573

EP - 582

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -